Our findings indicate that the combination of MK-2206 and WZB117 may exert a synergistic cytotoxic effect in both ER(+) MCF-7 and triple-negative MDA-MB-231 breast cancer cells via Akt inhibition and ROS induction, which may in turn cause DNA damage. The gene discussed is AKT1; the disease is breast carcinoma.